Arrowhead Pharmaceuticals Corp (ARWR)

29.54 +0.10 (0.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/11/19 *Est.)

Latest Headlines

Arrowhead Pharmaceuticals (ARWR) Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3 September 16, 2019 6:20 AM - StreetInsider Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3 September 16, 2019 3:00 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Sep 09 Filed by: PERRY MICHAEL S September 11, 2019 8:09 PM - SEC Filing Arrowhead Pharmaceuticals (ARWR) Weaker Amid Conf. Presentation September 5, 2019 1:57 PM - StreetInsider Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences August 30, 2019 4:00 PM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Collaborator Janssen Commences REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection August 28, 2019 7:41 AM - StreetInsider Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection August 28, 2019 7:30 AM - BizWire Arrowhead Research (ARWR) PT Raised to $46 at B.Riley/FBR August 19, 2019 5:29 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Reports First Patient Dosing in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease August 8, 2019 7:40 AM - StreetInsider Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease August 8, 2019 7:30 AM - BizWire Arrowhead Research (ARWR) PT Raised to $50 at Piper Jaffray August 6, 2019 6:04 AM - StreetInsider Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30 August 5, 2019 4:10 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: Aug 05 August 5, 2019 4:03 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Misses Q3 EPS by 8c, Revenues Miss August 5, 2019 4:01 PM - StreetInsider Arrowhead Pharmaceuticals Reports Fiscal 2019 Third Quarter Results August 5, 2019 4:00 PM - BizWire Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Third Quarter Results July 24, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Granted Orphan Drug Designation for ARO-ANG3 July 16, 2019 4:10 PM - StreetInsider Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3 July 16, 2019 4:00 PM - BizWire Arrowhead Pharmaceuticals to Participate in Roth RNA Revolution Conference July 8, 2019 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Jun 26 Filed by: Ferrari Mauro June 28, 2019 7:19 PM - SEC Filing Cantor Fitzgerald Downgrades Arrowhead Research (ARWR) to Neutral June 27, 2019 4:18 PM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Granted Fast Track Designation for ARO-AAT for Treatment of Alpha-1 Liver Disease June 27, 2019 7:31 AM - StreetInsider Arrowhead Pharmaceuticals Receives Fast Track Designation for ARO-AAT for Treatment of Alpha-1 Liver Disease June 27, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 21, 2019 6:45 PM - BizWire Arrowhead Pharmaceuticals (ARWR) Confirms it Received Orphan Drug Designation for ARO-APOC3 June 21, 2019 7:31 AM - StreetInsider Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3 June 21, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals (ARWR) Treatment of Familial Chylomicronemia Syndrome Granted FDA Orphan Status June 20, 2019 4:04 PM - StreetInsider Full Article List